Tourmaline Bio Stock Analysis

TRML Stock   15.41  0.70  4.76%   
Tourmaline Bio is undervalued with Real Value of 23.04 and Target Price of 48.67. The main objective of Tourmaline Bio stock analysis is to determine its intrinsic value, which is an estimate of what Tourmaline Bio is worth, separate from its market price. There are two main types of Tourmaline Bio's stock analysis: fundamental analysis and technical analysis.
The Tourmaline Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.

Tourmaline Stock Analysis Notes

About 16.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 20th of October 2023. Tourmaline Bio had 1:10 split on the 20th of October 2023. To find out more about Tourmaline Bio contact Sandeep MD at 646-481-9832 or learn more at https://www.tourmalinebio.com.

Tourmaline Bio Investment Alerts

Tourmaline Bio had very high historical volatility over the last 90 days
Tourmaline Bio was previously known as Talaris Therapeutics and was traded on NASDAQ Exchange under the symbol TALS.
Net Loss for the year was (42.12 M) with profit before overhead, payroll, taxes, and interest of 0.
Tourmaline Bio generates negative cash flow from operations
About 16.0% of the company outstanding shares are owned by corporate insiders
Latest headline from simplywall.st: Tourmaline Bio Insiders Placed Bullish Bets Worth US643.3k

Tourmaline Bio Upcoming and Recent Events

29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Tourmaline Largest EPS Surprises

Earnings surprises can significantly impact Tourmaline Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-11
2023-03-31-0.455-0.370.08518 
2024-05-13
2024-03-31-0.67-0.550.1217 
2023-11-14
2023-09-30-0.6-1.6421-1.0421173 
View All Earnings Estimates

Tourmaline Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 746.59 M.

Management Efficiency

At this time, Tourmaline Bio's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 219.3 M this year, although the value of Non Current Assets Total will most likely fall to about 809.2 K. Tourmaline Bio's management efficiency ratios could be used to measure how well Tourmaline Bio manages its routine affairs as well as how well it operates its assets and liabilities.
The analysis of Tourmaline Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Tourmaline Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Tourmaline Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.4958
Forward Dividend Yield
0.4958

Technical Drivers

As of the 23rd of July, Tourmaline Bio has the Variance of 12.06, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,488). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tourmaline Bio, as well as the relationship between them. Please validate Tourmaline Bio market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Tourmaline Bio is priced more or less accurately, providing market reflects its prevalent price of 15.41 per share. Given that Tourmaline Bio has information ratio of (0.1), we advise you to double-check Tourmaline Bio's current market performance to make sure the company can sustain itself at a future point.

Tourmaline Bio Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tourmaline Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tourmaline Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tourmaline Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tourmaline Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tourmaline Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tourmaline Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Tourmaline Bio Predictive Daily Indicators

Tourmaline Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tourmaline Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tourmaline Bio Corporate Filings

8K
27th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
3rd of June 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8K
13th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
19th of April 2024
Other Reports
ViewVerify
8K
19th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
15th of March 2024
An amended filing to the original Schedule 13G
ViewVerify

Tourmaline Bio Forecast Models

Tourmaline Bio's time-series forecasting models are one of many Tourmaline Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tourmaline Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tourmaline Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tourmaline Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tourmaline shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tourmaline Bio. By using and applying Tourmaline Stock analysis, traders can create a robust methodology for identifying Tourmaline entry and exit points for their positions.
Tourmaline Bio is entity of United States. It is traded as Stock on NASDAQ exchange.

Current Tourmaline Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tourmaline analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tourmaline analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
48.67Strong Buy6Odds
Tourmaline Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Tourmaline analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tourmaline stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tourmaline Bio, talking to its executives and customers, or listening to Tourmaline conference calls.
Tourmaline Analyst Advice Details

Tourmaline Stock Analysis Indicators

Tourmaline Bio stock analysis indicators help investors evaluate how Tourmaline Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tourmaline Bio shares will generate the highest return on investment. By understating and applying Tourmaline Bio stock analysis, traders can identify Tourmaline Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow8.5 M
Common Stock Shares Outstanding20.3 M
Total Stockholder Equity205 M
Property Plant And Equipment Net447 K
Cash140.7 M
Accounts Payable1.1 M
50 Day M A23.928
Total Current LiabilitiesM
Non Current Assets Total1.4 M
Non Currrent Assets Other974 K
Stock Based Compensation5.8 M

Additional Information and Resources on Investing in Tourmaline Stock

When determining whether Tourmaline Bio is a strong investment it is important to analyze Tourmaline Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tourmaline Bio's future performance. For an informed investment choice regarding Tourmaline Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.